Medical Emergency Decision-Making Guide: What to Do When Every Second Counts
Pexels image[/caption]
When faced with a medical emergency, the decisions made in the first few moments can be the difference between life and death. Whether you're responding to an accident, a sudden illness, or a worsening medical condition, having a clear understanding of how to act can save lives and reduce long-term complications. This guide offers essential steps and considerations for effective decision-making during a medical emergency.
Step 1: Assess the Situation
The first step is to quickly but calmly assess what is happening. Is the person conscious? Are they breathing? Is there any visible bleeding, signs of trauma, or indicators of a heart attack or stroke? Situational awareness is key. Do not panic—take a few deep breaths and focus on what needs to be done.
In many emergencies, calling for help is your top priority. If the person is unresponsive, not breathing, or experiencing symptoms like chest pain, severe bleeding, or sudden confusion, call emergency services immediately. When speaking with the dispatcher, provide clear and concise information about your location, the person’s condition, and any known medical history.
Shani Vaknine[/caption]
Shani Vaknine, Ph.D. candidate
Brain and Behavioral Sciences
The Hebrew University
MedicalResearch.com: What is the background for this study?
Response: We’ve long known that maternal stress during pregnancy can affect her baby’s development, but the molecular mechanisms behind this remained unclear. In our study, we explored how psychosocial stress experienced by the mother in late pregnancy influences tiny molecular fragments in the newborn’s blood. These fragments, called transfer RNA fragments or tRFs, were considered for many years to be disposable, but have recently been shown to have important biological functions.
Dr. Moyland[/caption]
Cynthia Moylan, MD
Associate Professor of Medicine,
Division of Gastroenterology
Duke University Health System
MedicalResearch.com: What is the background for this study?
Response: Metabolic dysfunction can lead to several health problems including metabolic dysfunction associated steatotic liver disease (MASLD), is driven by different factors, including: a person’s behavioral or lifestyle factors, environmental factors, and genetics. Limited research exists regarding genetic , epigenetic, or other factors that might impact development of metabolic dysfunction and MASLD. Our group has previously shown that alterations in DNA methylation (a type of epigenetic change), identifiable both in liver tissue and in blood, associate with MASLD and its progression to more severe liver disease. Whether DNA methylation that impacts imprinted gene expression also associates with metabolic dysfunction and MASLD risk remains largely unknown.
In this project, we explored imprinted genes: imprinting is a normal process that regulates genes by silencing one parental copy (either the maternal or the paternal) so that only one copy is expressed. Imprinting is an important biological process for development and has a disproportionate impact on disease - in fact, imprinted genes are hypothesized to affect 1-6% of the human genome. We sought to explore how altered DNA methylation of imprint control regions (ICRs) that help ‘control’ these imprinted genes might impact development of metabolic dysfunction in children (and hence potentially even in adults).
Summerlin is known for its clean streets, scenic walking trails, master-planned neighborhoods, and an overall reputation for being one of the safest, most peaceful areas in the Las Vegas Valley.
Unfortunately, that safety doesn’t mean pedestrians are always protected.
Even in a well-designed suburb like Summerlin, where people take pride in the planned beauty of the community, pedestrian accidents happen, and when they do, the effects go way beyond the physical. A
Luke Cavanah B.S.[/caption]
Luke Cavanah, BS
Department of Medical Education
Geisinger College of Health Sciences
Scranton, PA, 18509
MedicalResearch.com: What is the background for this study?
Response: Almost a third of patients with medication-treated major depressive disorder will fail at least two depressants—many patients failing more.1 Esketamine is an intranasal medication that was FDA-approved in 2019 for such patients when used in conjunction with an oral antidepressant.2 Esketamine also is unique from the more traditional oral antidepressants in its mechanism of action, quick onset, and evidence for treatment of acute suicidality.3 While esketamine has been of much interest for these last few years, a recent study found low and geographically variable use of this medication within the Medicaid population.4 We were interested in investigating esketamine treatment utilization among Medicare patients in 2019 and 2020.